Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

EMEA recommends veralipride withdrawal

    • 2 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    EMEA recommends veralipride withdrawal. Inpharma Wkly. 1598, 21 (2007). https://doi.org/10.1007/BF03272719

    Download citation


    • Adverse Effect
    • Marketing
    • Treatment Option
    • Regulatory Action
    • Member State